2020
DOI: 10.1080/10408398.2020.1829541
|View full text |Cite
|
Sign up to set email alerts
|

The anticancer potential of the dietary polyphenol rutin: Current status, challenges, and perspectives

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
44
0
3

Year Published

2020
2020
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 105 publications
(60 citation statements)
references
References 244 publications
0
44
0
3
Order By: Relevance
“…Rutin is a bioflavonoid glycoside with widespread pharmacological activities and has been applied for the treatment of diverse type of cancers, such as breast cancer, colon cancer, colorectal cancer, and leukemia [37]. Maeda et al.…”
Section: Resultsmentioning
confidence: 99%
“…Rutin is a bioflavonoid glycoside with widespread pharmacological activities and has been applied for the treatment of diverse type of cancers, such as breast cancer, colon cancer, colorectal cancer, and leukemia [37]. Maeda et al.…”
Section: Resultsmentioning
confidence: 99%
“…Hyperoside is a flavonoid-type flavone glycoside that has been reported to possess a wide range of pharmacological properties, such as an antioxidant agent (Park et al, 2016), anti-Alzheimer, anti-inflammatory and anticancer (Li et al, 2014).This is the same as astragalin, which presented several positive effects as antioxidant and anti-cancer (Riaz et al, 2018). Finally, rutin, which is a flavonoid, has antiinflammatory (Mostafa, 2018), anti-carcinogenic, and antioxidant activities (Farha et al, 2020).…”
Section: Discussionmentioning
confidence: 99%
“…In addition, the transport of poorly aqueous soluble compounds by a molecular-carrier allows improvement of its bioavailability and therefore, its biological activities [177]. The polyphenols mentioned in this review have been subjected to various forms of nanoformulation, especially resveratrol [178], curcumin [179], quercetin [180], catechins [181], and to a lesser degree, rutin [32] and apigenin [182]. It appears from the literature that in vitro and in vivo bioactivities of nanoformulated polyphenols are generally much better than those obtained with free polyphenols, particularly in the cancer field.…”
Section: Nanoformulation Improvementmentioning
confidence: 99%